Contribute towards policy development
Publish scientific publications
Compile conference presentations
Disseminate research findings internally and to universities and other stakeholders such as the community, CAGs and media
Write research and funding proposals
Obtain ethical approval from relevant regulatory bodies
Write research protocols and SOPs for qualitative studies
Develop and design research tools
Conduct fieldwork (data collection, interviews, etc.)
Monitor the progress of the research project
Write progress reports to stakeholders including networks and funders
Train the Research Team and other relevant staff
Conduct data analysis and write up results
Stay abreast with relevant research findings and collaborate closely with other investigators on related studies within the cluster
Serbia
leapfrogged the EU in inoculating its people by capitalising on “vaccination diplomacy” offered by foreign powers, a leading academic said.
The feat
created bitterness among its Balkan neighbours, Dr David Ellwood of Johns Hopkins University, said during a conference held on Wednesday by the London think tank Chatham House.
Belgrade’s swift decision to import vaccines from Russia and China, among other countries, enabled it to immunise a third of its population, compared with an average of only 22 per cent among the bloc’s 27 member states, said Dr Ellwood, who is Senior Adjunct Professor of European and Eurasian Studies at the university.
Powering Vaccine R&D: A Discussion on the Future of the Global Ecosystem for Vaccine R&D
The rapid development of COVID-19 vaccines is fueling a reimagining of what is possible for vaccine research and development (R&D). Join us for a panel discussion and Q&A reflecting on ideas offered in a forthcoming report by the Sabin-Aspen Vaccine Science & Policy Group, Powering Vaccine R&D: Opportunities for Transformation. This report will draw on historic lessons learned from vaccine development to outline opportunities to overhaul vaccine R&D practices to better prepare for the next pandemic, to make strides against diseases currently without vaccines, and to establish next-generation vaccines that offer meaningful improvements. Expert panelists will reflect on what it will take to transform the vaccine R&D ecosystem and how stakeholders at all levels can help support those efforts.
How has Serbia become the European vaccines champion? With help from its friends thenationalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenationalnews.com Daily Mail and Mail on Sunday newspapers.